✦ LIBER ✦

A phase III concurrent chemoradiotherapy trial with cisplatin and paclitaxel or docetaxel or gemcitabine in unresectable non-small cell lung cancer: KASLC 0401

✍ Scribed by Oh, In-Jae; Kim, Kyu-Sik; Kim, Young-Chul; Ban, Hee-Jung; Kwon, Yong-Soo; Kim, Yu-Il; Lim, Sung-Chul; Chung, Woong-Ki; Nam, Taek-Keun; Song, Joo-Young; Yoon, Mee-Sun; Ahn, Sung-Ja

Book ID: 121602466
Publisher: Springer
Year: 2013
Tongue: English
Weight: 405 KB
Volume: 72
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-013-2308-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase III trial of cisplatin/gemcitabine

Phase III trial of cisplatin/gemcitabine with or without vinorelbine or paclitaxel in advanced non-small cell lung cancer

✍ Pasquale Comella 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 366 KB

First-line gemcitabine with cisplatin or

First-line gemcitabine with cisplatin or epirubicin in advanced non-small-cell lung cancer: a phase III trial

✍ Wachters, F M; van Putten, J W G; Kramer, H; Erjavec, Z; Eppinga, P; Strijbos, J 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 133 KB

149 Concurrent Chemoradiotherapy with ci

149 Concurrent Chemoradiotherapy with cisplatin/docetaxel in Advanced Loco-Regional Non-Small Cell Lung Cancer (ALR-NSCLC): A phase I trial

✍ G. Rodrigues; M. Vincent; B. Dingle; E. Yu; J. Younus; R. Ash; R. Dar; A. Gratto 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 247 KB

9028 POSTER Gemcitabine and Cisplatin Fo

9028 POSTER Gemcitabine and Cisplatin Followed by Concurrent Gemcitabine and Radiotherapy or Sequential Radiotherapy Alone in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC)

✍ Kerner, G.S.M.A.; van Dullemen, L.F.A.; Wiegman, E.M.; van der Leest, A.H.D.; Wi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Phase III randomized trial of docetaxel

Phase III randomized trial of docetaxel in combination with cisplatin or carboplatin or vinorelbine plus cisplatin in advanced non-small cell lung cancer: Interim analysis

📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 494 KB

CALGB Study 9431: A randomized phase II

CALGB Study 9431: A randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy (Ind CT) and concomitant chemoradiotherapy (XRT) for unresectable stage III non-small cell lung cancer (NSCLC)

✍ Vokes, E.E; Leopold, K.A; Herndon, J.E; Crawford, J; Perry, M.C; Miller, A.A; Gr 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 114 KB